# MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease

> **NCT03178630** · — · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 150 (estimated)

## Conditions studied

- Autoimmune Liver Disease
- Autoimmune Hepatitis
- Primary Sclerosing Cholangitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03178630
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-02-20
- **Primary completion:** 2030-02
- **Final completion:** 2031-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03178630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03178630, "MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03178630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*